BioCentury | May 10, 1999
Analyst Picks & Changes

Analyst picks & changes

...Amgen Inc. (AMGN), Thousand Oaks, Calif. Business: Cancer BT Alex. Brown analyst Dennis Harp said the remarkably strong...
BioCentury | May 10, 1999
Analyst Picks & Changes

Analyst picks & changes

...Pharmacopeia Inc. (PCOP), Princeton, N.J. Business: Drug discovery BT Alex. Brown analyst Kevin Tang raised his rating to...
BioCentury | May 10, 1999
Analyst Picks & Changes

Analyst picks & changes

...QLT PhotoTherapeutics Inc. (QLTI), Vancouver, B.C. Business: Cancer BT Alex. Brown analyst Kevin Tang began coverage with a...
BioCentury | Mar 22, 1999
Analyst Picks & Changes

Analyst picks & changes

...Transkaryotic Therapies Inc. (TKTX), Cambridge, Mass. Business: Metabolic BT Alex. Brown analyst Dennis Harp raised his price target...
BioCentury | Mar 15, 1999
Analyst Picks & Changes

Analyst picks & changes

...Amgen Inc. (AMGN) , Thousand Oaks, Calif. Business: Biopharmaceuticals BT Alex. Brown analyst Dennis Harp raised his price...
BioCentury | Mar 8, 1999
Finance

Choppy waters

...the transgenic technology company, had a good week on a "buy" note put out by BT Alex. Brown...
BioCentury | Feb 16, 1999
Analyst Picks & Changes

Analyst picks & changes

...Pharmacopeia Inc. (PCOP), Princeton, N.J. Business: Drug discovery BT Alex. Brown analyst Kevin Tang raised his 1999 EPS...
BioCentury | Feb 1, 1999
Analyst Picks & Changes

Analyst picks & changes

...EPS estimate to $3.63 from $3.50. AMGN is her "analyst best call" for this year. BT Alex. Brown...
BioCentury | Jan 25, 1999
Analyst Picks & Changes

Analyst picks & changes

...Pharmacopeia Inc. (PCOP), Princeton, N.J. Business: Drug discovery BT Alex. Brown analyst Kevin Tang raised his 1999 EPS...
BioCentury | Jan 11, 1999
Analyst Picks & Changes

Analyst picks & changes

...He expects Enbrel for rheumatoid arthritis will rank as one of biotech's most successful products. BT Alex. Brown...
Items per page:
1 - 10 of 42
BioCentury | May 10, 1999
Analyst Picks & Changes

Analyst picks & changes

...Amgen Inc. (AMGN), Thousand Oaks, Calif. Business: Cancer BT Alex. Brown analyst Dennis Harp said the remarkably strong...
BioCentury | May 10, 1999
Analyst Picks & Changes

Analyst picks & changes

...Pharmacopeia Inc. (PCOP), Princeton, N.J. Business: Drug discovery BT Alex. Brown analyst Kevin Tang raised his rating to...
BioCentury | May 10, 1999
Analyst Picks & Changes

Analyst picks & changes

...QLT PhotoTherapeutics Inc. (QLTI), Vancouver, B.C. Business: Cancer BT Alex. Brown analyst Kevin Tang began coverage with a...
BioCentury | Mar 22, 1999
Analyst Picks & Changes

Analyst picks & changes

...Transkaryotic Therapies Inc. (TKTX), Cambridge, Mass. Business: Metabolic BT Alex. Brown analyst Dennis Harp raised his price target...
BioCentury | Mar 15, 1999
Analyst Picks & Changes

Analyst picks & changes

...Amgen Inc. (AMGN) , Thousand Oaks, Calif. Business: Biopharmaceuticals BT Alex. Brown analyst Dennis Harp raised his price...
BioCentury | Mar 8, 1999
Finance

Choppy waters

...the transgenic technology company, had a good week on a "buy" note put out by BT Alex. Brown...
BioCentury | Feb 16, 1999
Analyst Picks & Changes

Analyst picks & changes

...Pharmacopeia Inc. (PCOP), Princeton, N.J. Business: Drug discovery BT Alex. Brown analyst Kevin Tang raised his 1999 EPS...
BioCentury | Feb 1, 1999
Analyst Picks & Changes

Analyst picks & changes

...EPS estimate to $3.63 from $3.50. AMGN is her "analyst best call" for this year. BT Alex. Brown...
BioCentury | Jan 25, 1999
Analyst Picks & Changes

Analyst picks & changes

...Pharmacopeia Inc. (PCOP), Princeton, N.J. Business: Drug discovery BT Alex. Brown analyst Kevin Tang raised his 1999 EPS...
BioCentury | Jan 11, 1999
Analyst Picks & Changes

Analyst picks & changes

...He expects Enbrel for rheumatoid arthritis will rank as one of biotech's most successful products. BT Alex. Brown...
Items per page:
1 - 10 of 42